Biocytogen Pharmaceuticals-B(02315) plans to use idle funds for cash management.
BOSSTECH-B (02315) issued a notice, aiming to improve the efficiency of the company's use of its own funds. Meanwhile, ensuring the normal production and operation of the company and the safety of funds. The company plans to reasonably utilize some idle own funds for cash management, which can improve the efficiency of the use of own funds, increase the cash asset income of the company, and obtain more investment returns for the company and shareholders. The company plans to use temporarily idle own funds not exceeding RMB 500 million (including the principal) for cash management. Within the above-mentioned limit, the funds can be used in a revolving manner. The company plans to use temporarily idle own funds to purchase financial products issued by banks and other financial institutions with high security, good liquidity, and low risk for entrusted wealth management.
Biocytogen Pharmaceuticals-B(02315) announced that in order to improve the efficiency of the company's use of its own funds, while ensuring that it does not affect the company's normal production and operation and ensuring the safety of the funds, the company plans to reasonably utilize some idle own funds for cash management. This can improve the efficiency of using its own funds, increase the company's cash assets returns, and obtain more investment returns for the company and shareholders. The company plans to use up to RMB 500 million (including the principal) of temporarily idle own funds for cash management, and within the aforementioned limit, the funds can be rolled over for use. The company plans to use temporarily idle own funds to purchase wealth management products issued by banks and other financial institutions with high security, good liquidity, and low risk for entrusted wealth management.
Related Articles

CICC: Maintains C&D INTL GROUP (01908) Outperform rating, lowers target price to 19.1 HKD.

HK Stock Market Move | TIMEINTERCON(01729)rose by nearly 9% again, and the AI algorithm construction is in high demand. The MPO and server businesses are expected to benefit significantly.

HK Stock Market Move | SOUTH MANGANESE (01091) fell more than 12%, Tian Deng Company's manganese mines incurred significant losses, and Zunyi Company suffered severe losses.
CICC: Maintains C&D INTL GROUP (01908) Outperform rating, lowers target price to 19.1 HKD.

HK Stock Market Move | TIMEINTERCON(01729)rose by nearly 9% again, and the AI algorithm construction is in high demand. The MPO and server businesses are expected to benefit significantly.

HK Stock Market Move | SOUTH MANGANESE (01091) fell more than 12%, Tian Deng Company's manganese mines incurred significant losses, and Zunyi Company suffered severe losses.

RECOMMEND

New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026

117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026

“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026


